Nexam Chemical announces the outcome of the exercise of warrants
The board of directors of Nexam Chemical Holding AB (“Nexam Chemical” or “the Company”) today announces the outcome of the exercise of warrants of series TO 1, which were issued in connection with the Company’s rights issue of units during April 2020. The subscription rate was 97,17 percent and Nexam Chemical receives approximately SEK 13 million before issue costs.
During February 2020 Nexam Chemical announced a rights issue of units, each unit containing four (4) shares, one (1) warrant series TO 1 and one (1) warrant series TO 2. A total of 2,071,087 units were issued, corresponding to 2,071,087 warrants of series TO 1. One (1) warrant series TO 1 entitled the holder to subscribe for one (1) new share at a subscription price of SEK 6.50 during the period September 6 – 17, 2021. The outcome shows that approximately 97,17 percent of the outstanding warrants series TO 1 were exercised, meaning that 2,012,431 warrants series TO 1 were exercised for subscription of the same number of shares. Exercised warrants have been replaced with interim shares pending registration with the Swedish Companies Registration Office. The conversion of interim shares into shares is expected to take place within approximately two (2) weeks.
Through the exercise of warrants of series TO 1, the Company receives approximately SEK 13 million before issue costs. The number of shares in Nexam Chemical increases by 2,012,431 shares, from 78,903,367 shares to 80,915,798 shares. The share capital increases with SEK 38,700.60, from SEK 1,517,372.44 to SEK 1,556,073.04.
We would like to thank everyone who has participated in this process and support us in our efforts to achieve the growth goals. It is also with pleasure that we can state that so far it has been a good deal for those who participated in the issue in the spring of 2020, says Johan Arvidsson, CEO of Nexam Chemical
For questions regarding the warrants, please contact:
Erik Penser Bank AB
Telephone: 08-463 80 00
For more information, please contact:
Johan Arvidsson, CEO
Telephone: +46-708 97 44 39